Promoting the Quality of Medicines. 2016. Promoting the Quality of Medicines Program Annual Performance Report: Project Year 2016, October 1, 2015 – September 30, 2016. Submitted to the U.S. Agency for International Development by the Promoting the Quality of Medicines Program. Rockville, MD: United States Pharmacopeial Convention (USP)
(2017; 44 pages)


The Promoting the Quality of Medicines (PQM) program is a cooperative agreement between the United States Agency for International Development (USAID) and The United States Pharmacopeial Convention (USP). Since 1992, USP has worked cooperatively with USAID to support developing countries in addressing critical issues related to medicines information and quality. The PQM program provides technical assistance to build capacity of medicines regulatory authorities and quality assurance systems in countries with weak health systems. PQM also provides technical support to manufacturers of quality assured priority essential medicines for malaria, HIV/AIDS, tuberculosis, neglected tropical diseases and maternal and child health. There is increasing recognition of the burden of poor-quality medicines and their threat to public health, especially in low- and middle-income countries. Falsified and substandard medicines can cause treatment failure and adverse reactions, can increase morbidity and mortality, and may contribute to antimicrobial resistance. These medicines represent not only a waste of scarce resources but also a substantial risk to public health. Further, they risk undermining decades of health investments, including those made by USAID.

During FY16, PQM implemented projects in 34 countries and had four field offices in Ethiopia, Indonesia, Nigeria and the Philippines.

El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019